A short form of gross motor function measure for Fukuyama congenital muscular dystrophy

Takatoshi Sato1, Michiru Adachi2, Aya Matsuo2

  • 1Department of Pediatrics, Tokyo Women's Medical University, School of Medicine, 8-1 Kawadacho, Shinjuku-ku, Tokyo 162-8666, Japan.

Brain & Development
|March 9, 2020
PubMed
Abstract

Insights

The short form of the Gross Motor Function Measure for Fukuyama congenital muscular dystrophy (GMFM for FCMD) is a valid tool. This GMFM for FCMD may also reduce assessment time for patients.

Area of Science:

  • Neurology
  • Pediatrics
  • Rehabilitation Medicine

Background:

  • Fukuyama congenital muscular dystrophy (FCMD) is a rare genetic neuromuscular disorder.
  • Accurate assessment of motor function is crucial for managing FCMD.
  • Existing measures may be time-consuming or not specifically validated for FCMD.

Purpose of the Study:

  • To validate a shortened version of the Gross Motor Function Measure (GMFM) specifically for FCMD (GMFM for FCMD).
  • To assess the correlation between the GMFM for FCMD and the Ueda classification system.
  • To evaluate the efficiency of the GMFM for FCMD in terms of assessment time.

Main Methods:

  • A case series involving fifteen patients with FCMD at Tokyo Women's Medical University.
  • Comparison of the 68-item GMFM for FCMD (developed using Rasch analysis) with the original 88-item GMFM.
  • Assessment of the correlation between GMFM for FCMD scores and the Ueda classification.

Main Results:

  • A significant positive correlation (r = 0.935) was observed between the GMFM for FCMD and the Ueda classification.
  • The GMFM for FCMD demonstrated a tendency towards reduced assessment time compared to the original GMFM.

Conclusions:

  • The GMFM for FCMD appears to be a valid and appropriate motor function scale for individuals with FCMD.
  • This shorter measure may offer a more time-efficient assessment tool for clinicians and patients.

Related Concept Videos